Evelo Biosciences, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Evelo Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2022.
  • Evelo Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$12.4M, a 59.5% increase year-over-year.
  • Evelo Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$82.3M, a 31.2% increase year-over-year.
  • Evelo Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$115M, a 6.26% increase from 2021.
  • Evelo Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$122M, a 30.4% decline from 2020.
  • Evelo Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$93.7M, a 9.59% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$115M +$7.65M +6.26% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-16
2021 -$122M -$28.5M -30.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$93.7M -$8.19M -9.59% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$85.5M -$28.5M -50.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 -$56.9M -$28.9M -103% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-14
2017 -$28M -$14.7M -110% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-14
2016 -$13.3M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.